The impact of drug-related QT prolongation on FDA regulatory decisions

被引:29
|
作者
Park, Eunjung [1 ]
Willard, James [1 ]
Bi, Daoqin [1 ]
Fiszman, Monica [1 ]
Kozeli, Devi [1 ]
Koerner, John [1 ]
机构
[1] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
关键词
QT prolongation; Safety warning; Drug approval;
D O I
10.1016/j.ijcard.2013.07.136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:4975 / 4976
页数:2
相关论文
共 50 条
  • [41] Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)
    Weaver, Joyce
    La Grenade, Lois
    Kwon, Hyon
    Avigan, Mark
    [J]. DERMATOLOGIC THERAPY, 2009, 22 (03) : 204 - 215
  • [42] Drug-related psoriasis
    Ganeva, Maria
    Gancheva, Tanya
    Deliyska, Radostina
    Gancheva, Desislava
    Hristakieva, Evgenya
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (03): : 470 - 471
  • [43] DRUG-RELATED HEPATITIS
    IMOTO, S
    MATSUMOTO, H
    FUJII, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (01) : 129 - 129
  • [44] Drug-related crime
    Dvorsek, A
    [J]. POLICING IN CENTRAL AND EASTERN EUROPE: DEVIANCE, VIOLENCE, AND VICTIMIZATION, 2002, : 631 - 635
  • [45] DRUG-RELATED SCLERODERMA
    STERNBERG, EM
    VANWOERT, M
    YOUNG, S
    MAGNUSSEN, I
    OSTERLAND, CK
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 753 - 753
  • [46] Drug-related hepatotoxicity
    Mumoli, N
    Cei, M
    Cosimi, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (20): : 2192 - 2192
  • [47] DRUG-RELATED ALOPECIA
    BRODIN, MB
    [J]. DERMATOLOGIC CLINICS, 1987, 5 (03) : 571 - 579
  • [48] Drug-related toxidermia
    Pillon, Francois
    [J]. ACTUALITES PHARMACEUTIQUES, 2015, 54 (543): : 44 - 47
  • [49] Drug-related risks
    Klotz, Ulrich
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 983 - 984
  • [50] DRUG-RELATED POLYNEURITIS
    SCHUMM, F
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 100 (12) : 621 - 623